Paragon 28

Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Paragon 28 reports strong revenue growth and strategic initiatives outlook

Paragon 28 delivered robust financial results in Q4 2022 and full-year 2022, driven by strong revenue growth in the U.S. and international markets.
While facing challenges in achieving profitability and commercializing new technologies, the company's focus on innovation and market expansion presents opportunities for future growth.
With a solid liquidity position and strategic initiatives in place, Paragon 28 is well-positioned to capitalize on market opportunities and drive continued performance.
Investors can look forward to the company's projected revenue growth in 2023 and advancements in technology adoption for improved patient outcomes.

Paragon 28 reports record Q1 revenue, eyes global growth opportunities

Paragon 28 delivered robust financial performance in Q1 2023, driven by strong revenue growth in the U.S. and internationally. While challenges in achieving profitability persist, the company's strategic focus on product development and global market expansion positions it for continued success. Opportunities for growth include optimizing sales force efficiency, launching new products, and capitalizing on international market strength.

Paragon 28 reports strong Q2 performance, eyes international expansion

Paragon 28's Q2 2023 earnings call reflects robust financial performance, driven by international growth and successful product launches.
While facing supply chain challenges and anticipating a growth slowdown, the company remains focused on expanding its market reach and product offerings.
Investments in key markets and a strategic focus on emerging growth drivers underscore Paragon 28's commitment to sustained revenue growth.
Prudence in guidance and operational planning amidst uncertainties highlights the company's proactive approach to managing challenges and seizing opportunities.

Paragon 28 reports steady Q3 growth amidst supply chain challenges

Paragon 28's Q3 2023 earnings call highlighted steady revenue growth, product innovation, and strategic investments driving performance.
While facing supply chain challenges and billing day impacts, the company's focus on market-specific strategies and surgeon training remains a strength.
Securing a new credit facility and reaffirming revenue guidance underscore Paragon 28's commitment to future growth and market leadership.

Paragon 28 reports robust Q4 performance, eyes growth in 2024

Paragon 28's strong performance in Q4 2023, coupled with expectations for growth in 2024, positions the company well for the future. Despite challenges like supply chain issues, the company's focus on innovation and market expansion presents significant opportunities. By maintaining accountability and leveraging market opportunities, Paragon 28 aims to drive continued success.

Paragon 28 reports record Q1 revenue, eyes growth opportunities

Paragon 28's Q1 2024 performance reflects strong revenue growth and strategic product launches.
While facing challenges like negative cash flow and increased SG&A expenses, the company remains optimistic.
Opportunities lie in upcoming product launches, market expansion, and engagement with investors.
Overall, Paragon 28's resilience and growth trajectory position it well for future success in the medical devices sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Paragon 28, Inc. ("Paragon 28, Inc.") (NYSE:FNA) concerning possible violations of federal securities laws. Following the closure of the market on July 30, 2024, Paragon 28, Inc. filed an 8-K to the U.S. Securities and Exchange Commission (SEC) stating, "On July 30, 2024, the Audit Committee of the Board of Directors (the "Audit Committee") of Paragon 28, Inc. (the "Company"), in consultation with management, concluded that the Company's previously issued audited consolidated financial statements for the fiscal year ended December 31, 2023, contained within the Annual Report on Form 10-K for that year (and the associated audit report of the Company's independent registered accounting firm) and the unaudited condensed consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023, September 30, 2023, and March 31, 2024 should no longer be relied upon due to errors in such financial statements, and therefore a restatement of these prior financial statements is required.

ATTENTION Paragon 28, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE: FNA ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

FNA Investors Can Participate In The Paragon 28 Inc Securities Fraud Investigation With The Schall Law Firm

Paragon 28, Inc. (FNA) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

Lost Money on Paragon 28, Inc.(FNA)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

ATTENTION Paragon 28, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights

SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Paragon 28, Inc. (NYSE: FNA) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.

Johnson Fistel Law Firm Begins Investigation into Paragon 28 and Urges Shareholders with Losses To Contact The Firm

Lost Money on Paragon 28, Inc.(FNA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Paragon 28, Inc. (FNA)

LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE: FNA ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

FNA Investors Have Opportunity To Join Paragon 28 Inc Securities Fraud Investigation With The Schall Law Firm

NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Paragon 28, Inc. ("Paragon 28, Inc.") (NYSE:FNA) concerning possible violations of federal securities laws. Following the closure of the market on July 30, 2024, Paragon 28, Inc. filed an 8-K to the U.S. Securities and Exchange Commission (SEC) stating, "On July 30, 2024, the Audit Committee of the Board of Directors (the "Audit Committee") of Paragon 28, Inc. (the "Company"), in consultation with management, concluded that the Company's previously issued audited consolidated financial statements for the fiscal year ended December 31, 2023, contained within the Annual Report on Form 10-K for that year (and the associated audit report of the Company's independent registered accounting firm) and the unaudited condensed consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023, September 30, 2023, and March 31, 2024 should no longer be relied upon due to errors in such financial statements, and therefore a restatement of these prior financial statements is required.

ATTENTION FNA SHAREHOLDERS: Investors Who Lost Money on Paragon 28, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Paragon 28, Inc. ("Paragon 28, Inc.") (NYSE:FNA) concerning possible violations of federal securities laws. Following the closure of the market on July 30, 2024, Paragon 28, Inc. filed an 8-K to the U.S. Securities and Exchange Commission (SEC) stating, "On July 30, 2024, the Audit Committee of the Board of Directors (the "Audit Committee") of Paragon 28, Inc. (the "Company"), in consultation with management, concluded that the Company's previously issued audited consolidated financial statements for the fiscal year ended December 31, 2023, contained within the Annual Report on Form 10-K for that year (and the associated audit report of the Company's independent registered accounting firm) and the unaudited condensed consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023, September 30, 2023, and March 31, 2024 should no longer be relied upon due to errors in such financial statements, and therefore a restatement of these prior financial statements is required.

Paragon 28, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – FNA

NEW YORK, NY / ACCESSWIRE / August 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Paragon 28, Inc. ("Paragon 28, Inc.") (NYSE:FNA) concerning possible violations of federal securities laws. Following the closure of the market on July 30, 2024, Paragon 28, Inc. filed an 8-K to the U.S. Securities and Exchange Commission (SEC) stating, "On July 30, 2024, the Audit Committee of the Board of Directors (the "Audit Committee") of Paragon 28, Inc. (the "Company"), in consultation with management, concluded that the Company's previously issued audited consolidated financial statements for the fiscal year ended December 31, 2023, contained within the Annual Report on Form 10-K for that year (and the associated audit report of the Company's independent registered accounting firm) and the unaudited condensed consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023, September 30, 2023, and March 31, 2024 should no longer be relied upon due to errors in such financial statements, and therefore a restatement of these prior financial statements is required.

Levi & Korsinsky Announces an Investigation on Behalf of Paragon 28, Inc. (FNA) Shareholders Who May Have Been Affected by Fraud

NEW YORK, Aug. 04, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Paragon 28, Inc. (NYSE: FNA) resulting from allegations that Paragon 28 may have issued materially misleading business information to the investing public.

PARAGON 28, INC. ANNOUNCEMENT: If You Have Suffered Losses in Paragon 28, Inc. (NYSE: FNA), You Are to Contact The Rosen Law Firm About Your Rights

FNA ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you Lost Money on your Paragon 28, Inc. Investment

NEW YORK, NY / ACCESSWIRE / August 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Paragon 28, Inc. ("Paragon 28, Inc.") (NYSE:FNA) concerning possible violations of federal securities laws. Following the closure of the market on July 30, 2024, Paragon 28, Inc. filed an 8-K to the U.S. Securities and Exchange Commission (SEC) stating, "On July 30, 2024, the Audit Committee of the Board of Directors (the "Audit Committee") of Paragon 28, Inc. (the "Company"), in consultation with management, concluded that the Company's previously issued audited consolidated financial statements for the fiscal year ended December 31, 2023, contained within the Annual Report on Form 10-K for that year (and the associated audit report of the Company's independent registered accounting firm) and the unaudited condensed consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023, September 30, 2023, and March 31, 2024 should no longer be relied upon due to errors in such financial statements, and therefore a restatement of these prior financial statements is required.

Paragon 28, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - FNA

SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Paragon 28, Inc. (NYSE: FNA) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Paragon 28 (FNA) Admits Improper Accounting, Shares Fall – Hagens Berman

NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA) on behalf of Paragon 28 stockholders. Our investigation concerns whether Paragon 28 has violated the federal securities laws and/or engaged in other unlawful business practices.

PARAGON 28 ALERT: Bragar Eagel & Squire, P.C. is Investigating Paragon 28, Inc. on Behalf of Paragon 28 Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)---- $FNA #Investigation--The law firm of Kirby McInerney LLP is investigating potential claims against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA). The investigation concerns whether Paragon 28 and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [Click here to learn more about the investigation] On July 30, 2024, Paragon disclosed that the Company's previously issued financial statements from 2023 and 2.

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Paragon 28, Inc. (FNA)

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Paragon 28, Inc. (“Paragon” or the “Company”) (NYSE: FNA) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Paragon investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, y.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Paragon 28, Inc. (FNA) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Paragon 28, Inc. (“Paragon” or the “Company”) (NYSE: FNA) investors concerning the Company's possible violations of federal securities laws. On July 30, 2024, after market hours, Paragon disclosed that the Company's previously issued financial statements from 2023 and 2024 should no longer be relied upon “due to errors in such financial statements” related to “accounting” and would therefore r.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Paragon 28, Inc. (FNA) on Behalf of Investors

SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Paragon 28, Inc. (NYSE: FNA) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors.

Johnson Fistel Law Firm Begins Investigation into Paragon 28 and Urges Shareholders with Losses to Reach Out for More Information

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Paragon 28, Inc. (NYSE: FNA) resulting from allegations that Paragon 28 may have issued materially misleading business information to the investing public. So what: If you purchased Paragon 28 securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Rosen Law Firm Encourages Paragon 28, Inc. Investors to Inquire About Securities Class Action Investigation – FNA

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Paragon 28, Inc. (“Paragon” or the “Company”) (NYSE: FNA) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On July 30, 2024, after market hours, Paragon disclosed that the Company's previously issued financial statements from 2023 and 2024 should no longer be relied upon “due to errors.

The Law Offices of Frank R. Cruz Announces Investigation of Paragon 28, Inc. (FNA) on Behalf of Investors

Ideaya Biosciences Inc

DALLAS--(BUSINESS WIRE)--Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of its client, Schuylkill Haven Casket Company and Columbia Caskets Corp., to Victoriaville & Co. The acquisition closed July 9, 2024. Located in Schuylkill Haven, Pennsylvania, Haven Line Industries (became Haven Line industries in 1975 with the acquisition of Columbia Caskets Corp.) was established in 1919 and includes both Schuylkill.

Generational Group Advises Schuylkill Haven Casket Company and Columbia Caskets Corp. in its sale to Victoriaville & Co.

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2024 after market close on Thursday, August 8, 2024. The Company's management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time. Investors interested in listening to the conference call may do so by dialin.

News for Paragon 28 Stock (FNA)